According to Blueprint Medicines 's latest financial reports the company's total liabilities are โฌ0.81 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-12-31 | โฌ0.84 B | 1.9% |
2023-12-31 | โฌ0.83 B | 6.73% |
2022-12-31 | โฌ0.77 B | 213.27% |
2021-12-31 | โฌ0.24 B | 23.12% |
2020-12-31 | โฌ0.20 B | -7.06% |
2019-12-31 | โฌ0.21 B | 105.17% |
2018-12-31 | โฌ0.10 B | 38.43% |
2017-12-31 | โฌ76.48 M | 15.39% |
2016-12-31 | โฌ66.28 M | 107.54% |
2015-12-31 | โฌ31.93 M | 167.94% |
2014-12-31 | โฌ11.91 M | 192.32% |
2013-12-31 | โฌ4.07 M |